Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Dec 2025 is 4.70% vs 5.69% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is -37.26% vs -21.44% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Dec 2025 is 23.34% vs 48.73% in Sep 2025
Interest
QoQ Growth in quarter ended Dec 2025 is 8.27% vs -4.33% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
Compare Quarterly Results Of Piramal Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Dec 2025 is 4.70% vs 5.69% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -2.92% vs 12.54% in Dec 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is -37.26% vs -21.44% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -3,800.82% vs -63.60% in Dec 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Dec 2025 is 23.34% vs 48.73% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -42.05% vs 25.85% in Dec 2024
Quarterly - Interest
QoQ Growth in quarter ended Dec 2025 is 8.27% vs -4.33% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -13.62% vs -2.43% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024






